I
Interventional Spine
Patented percutaneous systems for treating back pain through implantable spinal devices
About Interventional Spine
Interventional Spine is a medical device company that specializes in the design, development, and commercialization of patented percutaneous systems for the treatment of back pain. The company's product portfolio includes a range of implantable devices for the spine that can be deployed using minimally invasive techniques.
Interventional Spine's target market includes healthcare providers, such as hospitals and clinics, that offer treatment for spinal conditions. The company's business model is based on the sale of its medical devices to these providers. Interventional Spine generates revenue through the sale of its products, as well as through licensing agreements with other medical device companies.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2000
- Headquarters
- Irvine, United States
- Employees
- 57
- Open positions
- None listed
- Dealroom signal
- 79.9/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Spinal Disease, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jan 2017 | $0 | — | DePuy Synthes | ↗ |
| DEBT✓Debt | Feb 2013 | $3.4M | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Interventional Spine is 190 monthly website visits. Interventional Spine's team grew 9.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later4 investors entered at this stage
Ascension Ventures- WCWexford Capital
Ascension
MedFocus Fund
Other known investors1 additional known investor
DePuy Synthes
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Interventional Spine on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Interventional Spine’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






